What is Intellia Therapeutics's net change in cash?

Intellia Therapeutics (NTLA) reported net change in cash of -$17.47M in Q1 2026.

How has Intellia Therapeutics's net change in cash changed year-over-year?

Intellia Therapeutics's net change in cash increased by 68.0% year-over-year, from -$54.6M to -$17.47M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Intellia Therapeutics NTLA Net Change in Cash

Net Change in Cash at other companies

Ionis PharmaceuticalsIONS

-$198.88M-999%

ALN

Alnylam PharmaceuticalsALNY

$53.61M0.0%

CRISPR TherapeuticsCRSP

$72.24M+215%

Beam TherapeuticsBEAM

-$6.64M-103%

Iovance Biotherapeutics, Inc.IOVA

$33.44M-40.3%

Viridian Therapeutics, Inc.VRDN

-$36.04M-317%

Other financials

Income statement

See full

Revenue$15.0M-9.5%

Operating income-$100.5M+16.8%

Net income-$96.2M+15.8%

EPS (diluted)-$0.81+26.4%

Balance sheet

See full

Cash & equivalents$134.7M+6.2%

Total debt$80.5M-32.5%

Total equity$620.9M-20.4%

Total assets$758.8M-23.1%

Cash flow

See full

Operating cash flow-$117.3M+21.2%

CapEx$79.0K-89.3%

Free cash flow-$117.4M+21.5%

Valuation

See full

Market cap$2.17B+106%

Profitability

See full

Operating margin-636.6%-202pp

Net margin-597%-194pp

FCF margin-550.2%-140pp

Returns & leverage

See full

Return on equity-56.3%-1.5pp

Debt / equity0.1×0.0×

Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Intellia Therapeutics's net change in cash?: Intellia Therapeutics (NTLA) reported net change in cash of -$17.47M in Q1 2026.
How has Intellia Therapeutics's net change in cash changed year-over-year?: Intellia Therapeutics's net change in cash increased by 68.0% year-over-year, from -$54.6M to -$17.47M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.